FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111811103> ?p ?o ?g. }

• W2111811103 endingPage "467" @default.
• W2111811103 startingPage "457" @default.
• W2111811103 abstract "Peptide hormone somatostatin and its receptors have a wide range of physiological functions and play a role in the treatment of numerous human diseases, including colorectal cancer. Octreotide, a synthetic somatostatin-analog peptide, inhibits growth of colonic cancer cells primarily by binding to G-protein coupled receptors and elicits cellular responses through second-messenger systems. Insulin also initiates mitogenic signals in certain cell types. The objective of the present study was to explore the effects of octreotide with or without insulin treatment, on Caco-2 and HT-29 human colon-cancer cell proliferation and to correlate their effects with the activation of telomerase reverse transcriptase (hTERT). The involvement of protein tyrosine phosphatases in the regulation of the anti-proliferative effect of octreotide was also evaluated. Sodium orthovanadate was used to reverse the anti- proliferative effect of octreotide. Telomerase activity was determined for each time point under octreotide and/or insulin treatment. Elevated expression of sst1, sst2 and sst5 was confirmed in both cell lines by RT-PCR. Immunocytochemistry detected sst1, sst2A, sst2B, sst3, sst4 and sst5 protein expression in the membranes of both cell lines. Octreotide inhibited the proliferation of Caco-2 and HT-29 cells in a time and dose-dependent manner. Insulin exerted proliferative effects in Caco-2 cells and octreotide reversed its effect in both cell lines. Sodium orthovanadate suppressed the anti-proliferative effect of octreotide both in Caco-2 and HT-29 cells. Telomerase activity was significantly reduced when Caco-2 cells were exposed to octreotide, under serum-free cultured medium. On the other hand, telomerase attenuation after octreotide treatment could not counteract the actions of insulin on both cells. Our data indicate that the use of octreotide could provide a possible therapeutic approach to the management of certain patients who suffer from colon cancer." @default.
• W2111811103 created "2016-06-24" @default.
• W2111811103 creator A5001919496 @default.
• W2111811103 creator A5014579164 @default.
• W2111811103 creator A5018853062 @default.
• W2111811103 creator A5041218708 @default.
• W2111811103 creator A5047902127 @default.
• W2111811103 creator A5057410453 @default.
• W2111811103 creator A5064800530 @default.
• W2111811103 creator A5089278623 @default.
• W2111811103 creator A5089744046 @default.
• W2111811103 date "2014-06-30" @default.
• W2111811103 modified "2023-10-03" @default.
• W2111811103 title "Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activity." @default.
• W2111811103 cites W124288231 @default.
• W2111811103 cites W1452074964 @default.
• W2111811103 cites W1481382242 @default.
• W2111811103 cites W1539638522 @default.
• W2111811103 cites W1546807582 @default.
• W2111811103 cites W1555945794 @default.
• W2111811103 cites W1572408626 @default.
• W2111811103 cites W1970617837 @default.
• W2111811103 cites W1978483208 @default.
• W2111811103 cites W1986027512 @default.
• W2111811103 cites W1997613971 @default.
• W2111811103 cites W1998767852 @default.
• W2111811103 cites W2003446134 @default.
• W2111811103 cites W2006247883 @default.
• W2111811103 cites W2008368359 @default.
• W2111811103 cites W2022085818 @default.
• W2111811103 cites W2022751076 @default.
• W2111811103 cites W2026331745 @default.
• W2111811103 cites W2029891973 @default.
• W2111811103 cites W2038527729 @default.
• W2111811103 cites W2040127137 @default.
• W2111811103 cites W2043234866 @default.
• W2111811103 cites W2048179918 @default.
• W2111811103 cites W2048922160 @default.
• W2111811103 cites W2049362063 @default.
• W2111811103 cites W2056129241 @default.
• W2111811103 cites W2069304529 @default.
• W2111811103 cites W2074842142 @default.
• W2111811103 cites W2080232093 @default.
• W2111811103 cites W2080318597 @default.
• W2111811103 cites W2081720784 @default.
• W2111811103 cites W2083309357 @default.
• W2111811103 cites W2085998656 @default.
• W2111811103 cites W2087761054 @default.
• W2111811103 cites W2088570873 @default.
• W2111811103 cites W2088672106 @default.
• W2111811103 cites W2089802648 @default.
• W2111811103 cites W2098547168 @default.
• W2111811103 cites W2110419228 @default.
• W2111811103 cites W2114918609 @default.
• W2111811103 cites W2117350664 @default.
• W2111811103 cites W2117431525 @default.
• W2111811103 cites W2117653902 @default.
• W2111811103 cites W2135726172 @default.
• W2111811103 cites W2137282180 @default.
• W2111811103 cites W2137969593 @default.
• W2111811103 cites W2138706637 @default.
• W2111811103 cites W2141527440 @default.
• W2111811103 cites W2145386424 @default.
• W2111811103 cites W2150081825 @default.
• W2111811103 cites W2151646340 @default.
• W2111811103 cites W2153920646 @default.
• W2111811103 cites W2157874223 @default.
• W2111811103 cites W2159318197 @default.
• W2111811103 cites W2163240506 @default.
• W2111811103 cites W2182612155 @default.
• W2111811103 cites W2410498641 @default.
• W2111811103 cites W2414894582 @default.
• W2111811103 cites W2416621373 @default.
• W2111811103 cites W250427044 @default.
• W2111811103 cites W30160296 @default.
• W2111811103 cites W4237540956 @default.
• W2111811103 cites W4300709752 @default.
• W2111811103 cites W4368055715 @default.
• W2111811103 doi "https://doi.org/10.18632/oncoscience.58" @default.
• W2111811103 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4284627" @default.
• W2111811103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25594044" @default.
• W2111811103 hasPublicationYear "2014" @default.
• W2111811103 type Work @default.
• W2111811103 sameAs 2111811103 @default.
• W2111811103 citedByCount "15" @default.
• W2111811103 countsByYear W21118111032015 @default.
• W2111811103 countsByYear W21118111032017 @default.
• W2111811103 countsByYear W21118111032018 @default.
• W2111811103 countsByYear W21118111032019 @default.
• W2111811103 countsByYear W21118111032020 @default.
• W2111811103 countsByYear W21118111032021 @default.
• W2111811103 countsByYear W21118111032023 @default.
• W2111811103 crossrefType "journal-article" @default.
• W2111811103 hasAuthorship W2111811103A5001919496 @default.
• W2111811103 hasAuthorship W2111811103A5014579164 @default.
• W2111811103 hasAuthorship W2111811103A5018853062 @default.
• W2111811103 hasAuthorship W2111811103A5041218708 @default.
• W2111811103 hasAuthorship W2111811103A5047902127 @default.

• next